Urological and Genital Diseases: Pelvic pain Urological and Genital Diseases
Conditions
Interventions
Sponsors
Department of Health
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 40 patients and 40 controls
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in severity of dysmenorrhoea, pelvic pain and deep dyspareunia as assessed by multidimensional analogue questionnaire between the group treated with levonogestrel-IUS and controls | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed